|
gptkbp:instanceOf
|
Contract Research Organization
|
|
gptkbp:acquiredBy
|
gptkb:Goldman_Sachs
gptkb:EQT
|
|
gptkbp:acquisitionYear
|
2021
|
|
gptkbp:CEO
|
Jamie Macdonald
|
|
gptkbp:delistedFromStockExchange
|
2017
|
|
gptkbp:foundedIn
|
1982
|
|
gptkbp:founder
|
Anne B. Sayigh
Josef von Rickenbach
|
|
gptkbp:headquartersLocation
|
gptkb:Newton,_Massachusetts,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Parexel
|
|
gptkbp:industry
|
gptkb:biotechnology
Pharmaceuticals
Clinical Research
|
|
gptkbp:notableClient
|
Major pharmaceutical companies
|
|
gptkbp:notableProject
|
COVID-19 vaccine trials
|
|
gptkbp:numberOfEmployees
|
~19,000
|
|
gptkbp:parentCompany
|
gptkb:Goldman_Sachs
gptkb:EQT
|
|
gptkbp:revenue
|
$2.5 billion (approx., 2021)
|
|
gptkbp:servesArea
|
Worldwide
|
|
gptkbp:services
|
Biostatistics
Data Management
Pharmacovigilance
Clinical Trials Management
Medical Writing
Regulatory Consulting
|
|
gptkbp:stockExchange
|
formerly NASDAQ (PRXL)
|
|
gptkbp:subsidiary
|
The Medical Affairs Company
|
|
gptkbp:website
|
https://www.parexel.com/
|
|
gptkbp:bfsParent
|
gptkb:IQVIA
gptkb:contract_research_organization
gptkb:contract_research_organizations
gptkb:Route_128_corridor
|
|
gptkbp:bfsLayer
|
7
|